rxstat › Shortages › Salbutamol Ipratropium Bromide
Salbutamol Ipratropium Bromide shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Salbutamol Ipratropium Bromide products are in shortage in Canada (1 of 6 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
In shortage since
Mar 10, 2017
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageAPO-SALVENT-IPRAVENT STERULES
0.5MG
2.5MG · SOLUTION · APOTEX INC
DIN 02266393 · since Mar 10, 2017, no end estimate · Disruption of the manufacture of the drug.
ResolvedIPRATROPIUM BROMIDE AND SALBUTAMOL SULPHATE INHALATION SOLUTION
2.5MG
0.5MG · SOLUTION · JUNO PHARMACEUTICALS CORP.
DIN 02483394 · ended Apr 16, 2025 · Demand increase for the drug.
ResolvedTEVA-COMBO STERINEBS
0.5MG
2.5MG · SOLUTION · TEVA CANADA LIMITED
DIN 02272695 · ended Apr 3, 2025 · Disruption of the manufacture of the drug.
ResolvedTEVA-COMBO STERINEBS
0.5MG
2.5MG · SOLUTION · TEVA CANADA LIMITED
DIN 02272695 · ended Dec 7, 2022 · Disruption of the manufacture of the drug.
ResolvedCOMBIVENT RESPIMAT
100MCG
20MCG · SOLUTION · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02419106 · ended Apr 22, 2022 · Other (Please describe in comments)
ResolvedTEVA-COMBO STERINEBS
0.5MG
2.5MG · SOLUTION · TEVA CANADA LIMITED
DIN 02272695 · ended Sep 2, 2020 · Disruption of the manufacture of the drug.
ResolvedTEVA-COMBO STERINEBS
0.5MG
2.5MG · SOLUTION · TEVA CANADA LIMITED
DIN 02272695 · ended Jul 29, 2020 · Disruption of the manufacture of the drug.
DiscontinuedCOMBIVENT UDV
0.2MG
1.0MG · SOLUTION · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02231675
ResolvedRATIO-IPRA SAL UDV
0.5MG
2.5MG · SOLUTION · TEVA CANADA LIMITED
DIN 02243789 · ended Jul 15, 2019 · Disruption of the manufacture of the drug.
ResolvedRATIO-IPRA SAL UDV
0.5MG
2.5MG · SOLUTION · TEVA CANADA LIMITED
DIN 02243789 · ended Jul 27, 2017 · Disruption of the manufacture of the drug.
ResolvedCOMBIVENT UDV
0.2MG
1.0MG · SOLUTION · BOEHRINGER INGELHEIM (CANADA) LTD LTEE
DIN 02231675 · ended Apr 5, 2017 · Disruption of the manufacture of the drug.
What's happening
Salbutamol Ipratropium Bromide is currently affected by an active shortage report filed with Health Canada by APOTEX INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Salbutamol Ipratropium Bromide is classified under “ADRENERGICS, INHALANTS” (ATC R03AL).
Recent changes
Common questions
When will Salbutamol Ipratropium Bromide be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Salbutamol Ipratropium Bromide in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.